Document
Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis
Academic Article
RDF description of Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis - http://irises.unisr.it/resource/item/105575
Generically Dependent Continuant
Article
Information Content Entity